Press "Enter" to skip to content

2 In the past several years.

Related StoriesResearchers associate neuroimaging data with reading deficits in sufferers with left-sided strokeGDF10 molecule defined as an integral player in repair mechanisms after strokePrimary care physicians frequently under – or over-estimate stroke and bleeding risk in AF patients Key Efficacy Findings from Post-Stroke Deficits Trial Improvement in walking was measured by the Timed 25-Feet Walk . Using the entire crossover design, walking rate increased while individuals were taking dalfampridine-ER in comparison to placebo . Individuals also demonstrated a positive modification on the Practical Independence Measurement scale while taking dalfampridine-ER in comparison to placebo.